<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the epidemics of Middle East respiratory syndrome coronavirus (MERS-CoV) and" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) caused alarming morbidity and mortality.3 While coronaviruses"/>
 <result pre="repurposed to treat a variety of viral infections, such as" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), Zika"/>
 <result pre="Middle East respiratory syndrome coronavirus (MERS-CoV), Zika virus (ZIKV), Japanese" exact="encephalitis" post="virus (JEV), hepatitis C virus (HCV), Ebola virus (EBOV),"/>
 <result pre="syndrome coronavirus (MERS-CoV), Zika virus (ZIKV), Japanese encephalitis virus (JEV)," exact="hepatitis" post="C virus (HCV), Ebola virus (EBOV), human rhinoviruses (HRVs),"/>
 <result pre="dengue virus four serotypes (DENV 1–4), West Nile virus (WNV)," exact="yellow fever" post="virus (YFV), and Japanese encephalitis virus (JEV). Many of"/>
 <result pre="West Nile virus (WNV), yellow fever virus (YFV), and Japanese" exact="encephalitis" post="virus (JEV). Many of these viruses are significant human"/>
 <result pre="mosquitoes. ZIKV infection can cause infants to be born with" exact="microcephaly" post="and can trigger neurologic conditions in adults such as"/>
 <result pre="infection. HCV can cause both acute and chronic hepatitis, and" exact="hepatitis" post="C is a major cause of liver cancer. It"/>
 <result pre="chronic hepatitis, and hepatitis C is a major cause of" exact="liver cancer." post="It was estimated that about 71 million people have"/>
 <result pre="infections worldwide.43 At present, there is no effective vaccine against" exact="hepatitis" post="C, although clinically approved therapeutics are available. Niclosamide was"/>
 <result pre="are widespread among humans and the primary cause of the" exact="common cold," post="posing serious health risks for patients with asthma, chronic"/>
 <result pre="risks for patients with asthma, chronic pulmonary disease, and severe" exact="bronchiolitis" post="in infants and children.49 Niclosamide is a weak lipophilic"/>
 <result pre="of their life, resulting in a lymphoproliferative disorder known as" exact="infectious mononucleosis." post="EBV infection was also found to be associated with"/>
 <result pre="to be associated with the development of several types of" exact="cancer" post="such as Burkitt’s lymphoma, Hodgkin’s lymphoma, and nasopharyngeal carcinoma.53"/>
 <result pre="et al. demonstrated that niclosamide inhibits EBV lytic replication in" exact="lymphoma" post="cells and epithelial cells and causes irreversible cell cycle"/>
 <result pre="be effective against a variety of human conditions such as" exact="cancer" post="and viral infections. Currently, there are four ongoing human"/>
 <result pre="there are four ongoing human clinical trials of niclosamide in" exact="ulcerative colitis," post="prostate carcinoma, and colorectal cancer in the ClinicalTrails.gov clinical"/>
 <result pre="clinical trials of niclosamide in ulcerative colitis, prostate carcinoma, and" exact="colorectal cancer" post="in the ClinicalTrails.gov clinical trials registry.56 Of note, niclosamide"/>
 <result pre="trials of niclosamide in ulcerative colitis, prostate carcinoma, and colorectal" exact="cancer" post="in the ClinicalTrails.gov clinical trials registry.56 Of note, niclosamide"/>
 <result pre="2019 novel coronavirus MERS-CoV Middle East respiratory syndrome coronavirus SARS-CoV" exact="severe acute respiratory syndrome" post="coronavirus HCV hepatitis C virus DENV dengue virus ZIKV"/>
 <result pre="respiratory syndrome coronavirus SARS-CoV severe acute respiratory syndrome coronavirus HCV" exact="hepatitis" post="C virus DENV dengue virus ZIKV Zika virus JEV"/>
 <result pre="C virus DENV dengue virus ZIKV Zika virus JEV Japanese" exact="encephalitis" post="virus WNV West Nile virus YFV yellow fever virus"/>
 <result pre="virus JEV Japanese encephalitis virus WNV West Nile virus YFV" exact="yellow fever" post="virus EBOV Ebola virus HRV human rhinovirus CHIKV Chikungunya"/>
 <result pre="C.-C.; ChenH.; HuiC. K.-M.; YuenK.-Y. (2020) A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
 <result pre="ArendR. C.; SamantR. S.; BuchsbaumD. J. (2014) Multi-targeted therapy of" exact="cancer" post="by niclosamide: A new application for an old drug."/>
 <result pre="(2016) Identification of niclosamide as a novel anticancer agent for" exact="adrenocortical carcinoma." post="Clin. Cancer Res.22, 3458–3466. 10.1158/1078-0432.CCR-15-2256.26873959 OsadaT.; ChenM.; YangX. Y.;"/>
 <result pre="of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium" exact="tuberculosis" post="(Beijing). Tuberculosis116, S28–S33. 10.1016/j.tube.2019.04.008. SunZ.; ZhangY. (1999) Antituberculosis activity"/>
 <result pre="ChenS.-C.; HongC.-F.; LinR.-K.; ChaoY.-S.; HsuJ. T. A. (2004) Inhibition of" exact="severe acute respiratory syndrome" post="coronavirus replication by niclosamide. Antimicrob. Agents Chemother.48, 2693–2696. 10.1128/AAC.48.7.2693-2696.2004.15215127"/>
 <result pre="Specific plant terpenoids and lignoids possess potent antiviral activities against" exact="severe acute respiratory syndrome" post="coronavirus. J. Med. Chem.50, 4087–4095. 10.1021/jm070295s.17663539 AnandK.; ZiebuhrJ.; WadhwaniP.;"/>
 <result pre="F.; AnandK.; BartlamM.; HilgenfeldR.; RaoZ. (2003) The crystal structures of" exact="severe acute respiratory syndrome" post="virus main protease and its complex with an inhibitor."/>
 <result pre="WuY.-T.; WongC.-H. (2005) Discovery of potent anilide inhibitors against the" exact="severe acute respiratory syndrome" post="3CL protease. J. Med. Chem.48, 4469–4473. 10.1021/jm050184y.15974598 GassenN. C.;"/>
 <result pre="10.1007/s00234-016-1687-9.27067205 ChambersT. J.; GrakouiA.; RiceC. M. (1991) Processing of the" exact="yellow fever" post="virus nonstructural polyprotein: a catalytically active NS3 proteinase domain"/>
 <result pre="CaoS.; ChenH.; SongY. (2013) Identification of three antiviral inhibitors against" exact="japanese encephalitis" post="virus from library of pharmacologically active compounds 1280. PLoS"/>
 <result pre="ChenH.; SongY. (2013) Identification of three antiviral inhibitors against japanese" exact="encephalitis" post="virus from library of pharmacologically active compounds 1280. PLoS"/>
 <result pre="RossignolJ.-F. (2011) Thiazolides as novel antiviral agents. 2. Inhibition of" exact="hepatitis" post="C virus replication. J. Med. Chem.54, 8670–8680. 10.1021/jm201264t.22059983 KorbaB."/>
 <result pre="KorbaB. E.; ElazarM.; LuiP.; RossignolJ.-F.; GlennJ. S. (2008) Potential for" exact="hepatitis" post="C virus resistance to nitazoxanide or tizoxanide. Antimicrob. Agents"/>
 <result pre="KuoS.-C.; HoY.-J. (2016) Antiviral activities of niclosamide and nitazoxanide against" exact="chikungunya" post="virus entry and transmission. Antiviral Res.135, 81–90. 10.1016/j.antiviral.2016.10.003.27742486 Marrugal-LorenzoJ."/>
 <result pre="LaiH.-C. (2016) Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in" exact="ovarian cancer." post="Oncotarget.7, 8993–9006. 10.18632/oncotarget.7113.26848771 WrappD.; WangN.; CorbettK. S.; GoldsmithJ. A.;"/>
 <result pre="ChenQ.-J.; DengF.; LiuL.-L.; YanB.; ZhanF.-X.; WangY.-Y.; XiaoG.-F.; ShiZ.-L. (2020) A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
</results>
